openPR Logo
Press release

Epilepsy Device Market: for Epilepsy Devices Poised to Exceed $1 Billion by 2031 | Growing CAGR of 5.1%

03-18-2024 01:52 PM CET | Health & Medicine

Press release from: Allied Market Research (AMR)

/ PR Agency: Allied Market Research (AMR)
Epilepsy Device Market: for Epilepsy Devices Poised to Exceed $1

The global epilepsy devices market isx experiencing a remarkable surge, poised to exceed a valuation of $1.1 billion by 2031, as revealed by the latest market analysis. According to the report released by Allied Market Research, the market was valued at $675.23 million in 2021 and is projected to grow at a CAGR of 5.1% from 2022 to 2031.


๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐…๐จ๐ซ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ: https://www.alliedmarketresearch.com/request-sample/A14821


Epilepsy devices play a critical role in seizure detection and monitoring, offering hope and improved quality of life for millions affected by epilepsy worldwide. With advancements in technology, including deep brain stimulation (DBS), vagus nerve stimulation (VNS), and responsive neurostimulation (RNS), coupled with innovative wearable and conventional devices, the landscape of epilepsy management is rapidly evolving.

Epilepsy Devices Market Trends are rise in the geriatric population who are more susceptible to developing neurological diseases, a rise in the adoption of technologically advanced epilepsy devices, and an increase in awareness toward the benefits of using epilepsy devices in the effective diagnosis of seizures. For instance, according to National Health Service, epilepsy starts in people aged over 60 years. Furthermore, cryptogenic or stroke-related seizures are most common in elderly people.


๐Š๐ž๐ฒ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐Ÿ๐ซ๐จ๐ฆ ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:

โ—‰ ๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ข๐œ๐š๐ฅ ๐€๐๐ฏ๐š๐ง๐œ๐ž๐ฆ๐ž๐ง๐ญ๐ฌ: The market showcases a diverse range of products, including conventional and wearable devices, EEG, Electrocardiography (EKG), Surface Electromyography (sEMG), Video Detection Systems, and more, catering to varied patient needs.

โ—‰ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ฒ๐ง๐š๐ฆ๐ข๐œ๐ฌ: With a forecast period spanning from 2021 to 2031, the report provides a comprehensive analysis of market dynamics, identifying key drivers, restraints, and opportunities shaping the epilepsy devices market.

โ—‰ ๐†๐ฅ๐จ๐›๐š๐ฅ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค: Major countries in each region are mapped based on their revenue contribution to the global market, providing valuable insights for stakeholders worldwide.

โ—‰ ๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐ฏ๐ž ๐‹๐š๐ง๐๐ฌ๐œ๐š๐ฉ๐ž: Key market players such as Medpage Ltd, Abbott Laboratories, Empatica, Inc., Natus Medical Incorporated, and others are positioned strategically, enabling benchmarking and fostering a deeper understanding of market dynamics.


๐„๐ง๐ช๐ฎ๐ข๐ซ๐ž ๐๐ž๐Ÿ๐จ๐ซ๐ž ๐๐ฎ๐ฒ๐ข๐ง๐ : https://www.alliedmarketresearch.com/purchase-enquiry/A14821


๐‹๐ž๐š๐๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ-

โ— Cadwell Industries

โ— Natus Medical Compumedics Limited

โ— Empatica Inc.

โ— LivaNova PLC

โ— Masimo Corporation

โ— Medpage Ltd.

โ— Medtronic plc

โ— Boston Scientific Corporation

โ— Abbott Laboratories


๐’๐ญ๐š๐ค๐ž๐ก๐จ๐ฅ๐๐ž๐ซ๐ฌ ๐’๐ญ๐š๐ง๐ ๐ญ๐จ ๐๐ž๐ง๐ž๐Ÿ๐ข๐ญ ๐Ÿ๐ซ๐จ๐ฆ:

โ—‰ Quantitative analysis of market segments and current trends

โ—‰ Insights into prevailing market opportunities

โ—‰ Porter's five forces analysis for profit-oriented business decisions

โ—‰ Identification of key growth strategies and application areas

With an emphasis on innovation and patient-centric care, the epilepsy devices market is poised for significant growth, revolutionizing epilepsy management globally.

๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ, ๐‘๐ž๐ฌ๐ญ๐ซ๐š๐ข๐ง๐ญ๐ฌ, ๐š๐ง๐ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ-

Rise in the prevalence of old age population that are more vulnerable to epilepsy and increase in awareness regarding the use of epilepsy devices drives the growth of the global epilepsy devices market. On the other hand, strict government regulations concerning the manufacturing of epilepsy device products and product approvals impede the growth to some extent. However, increase in focus on developing cost-effective epilepsy devices and surge in R&D investments in the discovery & development of advanced epilepsy devices are expected to create lucrative opportunities in the industry.

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ:

David Correa

Portland, OR, United States

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975

help@alliedmarketresearch.com

Web: https://www.alliedmarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Epilepsy Device Market: for Epilepsy Devices Poised to Exceed $1 Billion by 2031 | Growing CAGR of 5.1% here

News-ID: 3434530 • Views: โ€ฆ

More Releases from Allied Market Research (AMR)

Controlled Release Fertilizers Market 2026-2031: Insights into Growth Trends and Recent Developments
Controlled Release Fertilizers Market 2026-2031: Insights into Growth Trends and โ€ฆ
The global controlled release fertilizers (CRF) market is witnessing steady growth, driven by rising global food demand, environmental concerns, and increasing adoption of advanced agricultural practices. According to a report published by Allied Market Research titled "Controlled Release Fertilizers Market by Type, Mode of Application, and End Use: Global Opportunity Analysis and Industry Forecast, 2021-2031," the market was valued at $2.3 billion in 2021 and is projected to reach $4.3 billionโ€ฆ
Industry Analysis Report on Car Care Solvents 2026: Major Trends, Growth Factors and Forecast Overview
Industry Analysis Report on Car Care Solvents 2026: Major Trends, Growth Factors โ€ฆ
The global car care solvents market is witnessing steady growth, fueled by strict government regulations promoting vehicle cleanliness, rising disposable income, and increased consumer spending on repair and maintenance activities. According to a recent report published by Allied Market Research, titled "Car Care Solvents Market by Type, Application, and End-use: Global Opportunity Analysis and Industry Forecast, 2021-2031", the market was valued at $1.1 billion in 2021 and is projected to reachโ€ฆ
Global Market Report on Textile Fabrics 2026 | Business Expansion, Growth Drivers and Trends Through 2031
Global Market Report on Textile Fabrics 2026 | Business Expansion, Growth Driver โ€ฆ
The global Textile Fabrics Market is witnessing significant growth, fueled by the rapid expansion of the fashion and apparel industry, rising investments, growth in the oil & gas sector, and continuous advancements in the chemical industry. According to a report published by Allied Market Research, titled "Textile Fabrics Market by Fabric Type (Cotton, Polyester, Polyamide, Others), by Application (Fashion & Clothing, Household, Technical): Global Opportunity Analysis and Industry Forecast, 2021-2031", theโ€ฆ
Drivers of the Needle Coke Market from 2026 to 2031: Regional Perspectives and Size Analysis
Drivers of the Needle Coke Market from 2026 to 2031: Regional Perspectives and S โ€ฆ
The rising demand for super premium grade needle coke known for its low sulfur content, minimal puffing rate, low coefficient of thermal expansion, and large particle size is significantly driving the expansion of the global needle coke market. According to a report by Allied Market Research titled "Needle Coke Market by Type (Petroleum Based, Coal Based), by Application (Graphite Electrodes, Lithium-ion Battery, Special Carbon Material, Rubber Compounds, Others): Global Opportunity Analysisโ€ฆ

All 5 Releases


More Releases for Epilepsy

Gavin Hogarth Shares a Personal and Informative Perspective on Living With Epile โ€ฆ
Image: https://www.globalnewslines.com/uploads/2026/01/1769444744.jpg Liverpool, England - Author Gavin Hogarth offers a candid and educational look into life with epilepsy in his book, Epilepsy, What Is It? [https://www.amazon.com/Epilepsy-What-Gavin-Hogarth/dp/1836152698/ref] Drawing from his own lived experience, Hogarth shares how the condition has shaped, challenged, and changed his life, while providing practical insight for readers seeking to better understand epilepsy. Written with honesty and purpose, Epilepsy, What Is It? aims to raise awareness and educate those whoโ€ฆ
Adult mitochondrial epilepsy presentation
Mitochondrial epilepsy is a rare but severe neurological condition caused by genetic mutations that impair mitochondrial function, disrupting cellular energy production in the brain. Patients often present with seizures, developmental delays, and neurodegeneration. It is closely associated with broader mitochondrial diseases such as MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes) and Leigh syndrome. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72869 Due to its rarity and complexity, treatment optionsโ€ฆ
Portable Epilepsy Monitoring Market in 2025
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Portable Epilepsy Monitoring Market- (By Product Type (Device Type (Chest Sensor, Watch Sensor, Monitors, Cameras, Mattresses and Pillows, and Others) and Service), By End User (Hospitals, Ambulatory Surgery Centres & Clinics, Neurology Centres, and Home Care Settings)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Globalโ€ฆ
Top 10 Epilepsy Companies Analysis (2024)
Epilepsy also known as seizure disorder, is a chronic noncommunicable disease that affects brain. Epilepsy affects people of all races, ethnic backgrounds, genders, and ages. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00016405/?utm_source=OpenPR&utm_medium=10129 Major Companies operating in the Epilepsy Market are: โ€ข Idexx Laboratories Inc. โ€ข PBD Biotech Ltd โ€ข Thermo Fisher Scientific Inc. โ€ข Innovative Diagnostics SAS โ€ข Neogen Corp โ€ข Enfer Labs โ€ข bioMerieux SA โ€ข Ring Biotechnology Co Ltd โ€ข Bionote Inc. โ€ข Shenzhen Bioeasy Biotechnology Co Ltd. Contact Us: If you have any queries about this report or ifโ€ฆ
Epilepsy with Myoclonic - Atonic Seizures Therapeutics Market - Breaking the Sei โ€ฆ
Newark, New Castle, USA: The "Epilepsy with Myoclonic-Atonic Seizures Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Epilepsy with Myoclonic - Atonic Seizures Therapeutics Market: https://www.growthplusreports.com/report/epilepsy-with-myoclonic-atonic-seizures-therapeutics-market/8029 Thisโ€ฆ
Rising Instances of Pediatric Epilepsy to Pave Novel Growth Avenues in Epilepsy โ€ฆ
Owing to large scale prevalence of epilepsy cases, inclusive of pediatric epilepsy, the market for epilepsy drugs is likely to remain agile in the coming years. Prevalent amongst both male and female demographics alike, epilepsy is a critical condition that affects the brain both partially as well as in whole. Lucrative reimbursement policies, coupled with growing patient awareness about novel therapeutics are likely to reflect favorably on the growth curveโ€ฆ